Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beate Pfistner

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
European Journal of Haematology. Supplementum|July 13, 2005
Current treatment strategies of the German Hodgkin Study Group (GHSG)Beate Klimm, Volker Diehl, Beate Pfistner, et al.
Onkologie|June 4, 2005
Quality management for clinical trials within the German Competence Network Paediatric Oncology and HaematologyUrsula Creutzig, Martin Zimmermann, Julia Hannemann, et al.
Blood|September 25, 2007
Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG)Michal Sieniawski, Thorsten Reineke, Lucia Nogova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2005
Hodgkin's lymphoma in elderly patients: a comprehensive retrospective analysis from the German Hodgkin's Study GroupAndreas Engert, Veronika Ballova, Heinz Haverkamp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2005
Role of hematotoxicity and sex in patients with Hodgkin's lymphoma: an analysis from the German Hodgkin Study GroupBeate Klimm, Thorsten Reineke, Heinz Haverkamp, et al.
Clinical Trials (London, England)|November 10, 2009
Risk analysis and risk adapted on-site monitoring in noncommercial clinical trialsOana Brosteanu, Peggy Houben, Kristina Ihrig, et al.
Blood|July 26, 2003
Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphomaLudmila Boudová, Emina Torlakovic, Jan Delabie, et al.
Rontgenpraxis; Zeitschrift Fur Radiologische Technik|May 4, 2004
[New therapeutic strategies for Hodgkin lymphoma in cooperation of radiation oncology and medical oncology]Hans Theodor Eich, Rolf-Peter M Müller, Sascha Ansén, et al.
International Journal of Radiation Oncology, Biology, Physics|August 21, 2007
A Contribution to solve the problem of the need for consolidative radiotherapy after intensive chemotherapy in advanced stages of Hodgkin's lymphoma--analysis of a quality control program initiated by the radiotherapy reference center of the German Hodgkin Study Group (GHSG)Hans Theodor Eich, Axel Gossmann, Andreas Engert, et al.
Lancet (London, England)|June 28, 2002
Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trialNorbert Schmitz, Beate Pfistner, Michael Sextro, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
European Journal of Haematology. Supplementum|July 13, 2005
Current treatment strategies of the German Hodgkin Study Group (GHSG)Beate Klimm, Volker Diehl, Beate Pfistner, et al.
Onkologie|June 4, 2005
Quality management for clinical trials within the German Competence Network Paediatric Oncology and HaematologyUrsula Creutzig, Martin Zimmermann, Julia Hannemann, et al.
Blood|September 25, 2007
Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG)Michal Sieniawski, Thorsten Reineke, Lucia Nogova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2005
Hodgkin's lymphoma in elderly patients: a comprehensive retrospective analysis from the German Hodgkin's Study GroupAndreas Engert, Veronika Ballova, Heinz Haverkamp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2005
Role of hematotoxicity and sex in patients with Hodgkin's lymphoma: an analysis from the German Hodgkin Study GroupBeate Klimm, Thorsten Reineke, Heinz Haverkamp, et al.
Clinical Trials (London, England)|November 10, 2009
Risk analysis and risk adapted on-site monitoring in noncommercial clinical trialsOana Brosteanu, Peggy Houben, Kristina Ihrig, et al.
Blood|July 26, 2003
Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphomaLudmila Boudová, Emina Torlakovic, Jan Delabie, et al.
Rontgenpraxis; Zeitschrift Fur Radiologische Technik|May 4, 2004
[New therapeutic strategies for Hodgkin lymphoma in cooperation of radiation oncology and medical oncology]Hans Theodor Eich, Rolf-Peter M Müller, Sascha Ansén, et al.
International Journal of Radiation Oncology, Biology, Physics|August 21, 2007
A Contribution to solve the problem of the need for consolidative radiotherapy after intensive chemotherapy in advanced stages of Hodgkin's lymphoma--analysis of a quality control program initiated by the radiotherapy reference center of the German Hodgkin Study Group (GHSG)Hans Theodor Eich, Axel Gossmann, Andreas Engert, et al.
Lancet (London, England)|June 28, 2002
Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trialNorbert Schmitz, Beate Pfistner, Michael Sextro, et al.
Pageof 2